Archive - January 2023
FDA Approves Airsupra (albuterol/budesonide) Metered-Dose Inhaler to Reduce the Risk of Asthma Exacerbations
CSL Vifor: US Launch Leader
CSL Vifor: Werkstudent Marketing Nephrologie (w/m/d)
NextPoint Therapeutics announces $80 million Series B financing co-led by Leaps by Bayer and Sanofi Ventures to advance novel immuno-oncology programs
AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline
FDA Approves Leqembi (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer’s Disease
FDA grants Accelerated Approval for Alzheimer’s disease treatment
Incurable liver disease may prove curable